Initial experience in the clinical use of everolimus-eluting bioresorbable vascular scaffold (BVS) in a single institution

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1536-1537

  Liang, Michael ^a   Kajiya, Takashi ^a   Lee, Chi Hang ^a   Chan, Mark ^a   Teo, Swee Guan ^a   Chan, Koo Hui ^a   Tan, Huay Cheem ^a   Low, Adrian F ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Bioresorbable vascular scaffold (BVS); Coronary artery disease; Percutaneous coronary intervention

Indexed keywords

ANTITHROMBOCYTIC AGENT; EVEROLIMUS;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; BALLOON CATHETER; BIORESORBABLE VASCULAR SCAFFOLD; BLOOD VESSEL DIAMETER; CARDIAC IMPLANT; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR PROCEDURE; CLINICAL ARTICLE; COMORBIDITY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE CLASSIFICATION; DRUG ELUTING STENT; FEMALE; HUMAN; INFORMED CONSENT; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LETTER; MALE; METAL STENT; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QUANTITATIVE CORONARY ANALYSIS; RIGHT CORONARY ARTERY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT INDICATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; VASCULAR ACCESS; VASODILATATION;

BIORESORBABLE VASCULAR SCAFFOLD (BVS); CORONARY ARTERY DISEASE; PERCUTANEOUS CORONARY INTERVENTION;

ABSORBABLE IMPLANTS; ANIMALS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS;

EID: 84885330957     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.12.037     Document Type: Article

References (9)

1. Bourantas CV, Onuma Y, Farooq V, Zhang Y, Garcia-Garcia HM, Serruys PW. Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications. Int J Cardiol 2013 Jul 15;167(1):11-21.
2. Stone GW, Rizvi A, Newman W, et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med 2010;362:1663-74.
3. Grube E, Chevalier B, Smits P, et al. The SPIRIT V study: a clinical evaluation of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions. JACC Cardiovasc Interv 2011;4:168-75.
4. Smits PC, Kedhi E, Royaards KJ, et al. 2-year follow-up of a randomized controlled trial of everolimus-and paclitaxel-eluting stents for coronary revascularization in daily practice the COMPARE (comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTE stent in all-comers: a randomized open label trial) trial. J Am Coll Cardiol 2011 Jun 28;58(1):11-8.
5. Dudek D. Evaluation of the ABSORB everolimus eluting bioresorbable vascular scaffold (ABSORB BVS) in the treatment of patients with de novo native coronary artery lesions: 2 year clinical results of ABSORT Cohort B trial. J Am Coll Cardiol 2012;59:E319.
6. Onuma Y, Serruys PW, Perkins LE, et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimuseluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation 2010;122:2288-300.
7. Diletti R, Farooq V, Girasis C, et al. Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB Cohort B trial. Heart 2013 Jan;99(2):98-105.
8. Serruys PW, Onuma Y, Ormiston JA, et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation 2010;122:2301-12.
9. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011;58: e44-e122.